Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ataxin 1 anticorps (AA 645-815)

Cet anticorps Souris Monoclonal détecte spécifiquement Ataxin 1 dans WB, ELISA et FACS. Il présente une réactivité envers Humain et Souris.
N° du produit ABIN7193320

Aperçu rapide pour Ataxin 1 anticorps (AA 645-815) (ABIN7193320)

Antigène

Voir toutes Ataxin 1 (ATXN1) Anticorps
Ataxin 1 (ATXN1)

Reactivité

  • 77
  • 63
  • 36
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain, Souris

Hôte

  • 66
  • 48
  • 1
Souris

Clonalité

  • 66
  • 49
Monoclonal

Conjugué

  • 46
  • 8
  • 7
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Ataxin 1 est non-conjugé

Application

  • 84
  • 43
  • 42
  • 35
  • 34
  • 23
  • 23
  • 23
  • 9
  • 6
  • 6
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Clone

2B8A2
  • Épitope

    • 28
    • 21
    • 17
    • 12
    • 7
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 645-815

    Fonction

    ATXN1 Antibody

    Purification

    Purified antibody

    Immunogène

    Purified recombinant fragment of human ATXN1 (AA: 645-815) expressed in E. Coli.

    Isotype

    IgG1
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified antibody in PBS with 0.05 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Antigène

    Ataxin 1 (ATXN1)

    Autre désignation

    ATXN1

    Sujet

    The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames.

    Poids moléculaire

    86.9 kDa

    UniProt

    P54253

    Pathways

    Synaptic Membrane
Vous êtes ici:
Chat with us!